| Pharmaceutical active ingredients: |
| Mitomycin |
| Available forms, composition and doses of Mutamycin: |
| Injectable; Injection; Mitomycin 20 mgInjectable; Injection; Mitomycin 5 mg |
| Mutamycin medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01DC03 - Mitomycin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bristol-Myers Squibb |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Mucomyst with Isoproterenol | Acetylcysteine; Isoproterenol Hydrochloride | Bristol-Myers Squibb; Mead Johnson Nutritionals |
| MucomystEndo | Acetylcysteine | Bristol-Myers Squibb |
| Multilind | Nystatin; Zinc Oxide | Bristol-Myers Squibb; Dermapharm; Stada |
| Multilind Heilpaste | Nystatin; Zinc Oxide | Bristol-Myers Squibb; Dermapharm; Stada |
| Multilind Suspension | Nystatin | Bristol-Myers Squibb; Dermapharm; Stada |
| Mutamycine | Mitomycin | Bristol-Myers Squibb |
| Mycolog | Neomycin Sulfate; Nystatin; Triamcinolone Acetonide | Bristol-Myers Squibb |
| Mycolog-II | Nystatin; Triamcinolone Acetonide | Bristol-Myers Squibb; Apothecon |
| Mycostatin | Nystatin | Bristol-Myers Squibb; Apothecon; ConvaTec; Dermapharm; DKSH; Institute of Pharmaceutical Research and Technology; Sanofi-Aventis; Sarabhai Piramal Pharma; Westwood-Squibb |
| Mycostatin Forte | Nystatin | Bristol-Myers Squibb; Sanofi-Aventis |